Bacterial L-forms require peptidoglycan synthesis for cell division

BioEssays

Volumn 29, Issue 12, 2007, Pages 1189-1191

  Casadesús, Josep ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; PEPTIDOGLYCAN;

ARTICLE; BACTERIAL CELL; BACTERIAL CELL WALL; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIAL STRAIN; CELL DIVISION; ESCHERICHIA COLI; EUKARYOTIC CELL; MYCOPLASMA; NONHUMAN; PROTOPLAST; RELAPSE;

BACTERIA; CELL DIVISION; CELL WALL; ESCHERICHIA COLI; PEPTIDOGLYCAN;

ANIMALIA; BACTERIA (MICROORGANISMS); EUKARYOTA; MYCOPLASMATALES;

EID: 36849047742     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/bies.20680     Document Type: Article

References (22)

1. Joseleau-Petit D, Liébart JC, Ayala JA, D'Ari R. 2007. Unstable Escherichia coli L-forms revisited: growth requires peptidoglycan synthesis. J Bacteriol 189:6512-6520.
2. Weiss DS. 2004. Bacterial division and the bacterial ring. Mol Microbiol 54:588-597.
3. Margolin W. 2005. FtsZ and the division of prokaryotic cells and organelles. Nat Rev Mol Cell Biol 6:862-871.
4. Marmion BP. 1990. Eaton agent-science and scientific acceptance: a historical commentary. Rev Infect Dis 12:338-353.
5. Dienes L, Weinberger HJ. 1951. The L forms of bacteria. Bacteriol Rev 15:245-288.
6. Klieneberger-Nobel E. 1960. L forms of bacteria. In: Gunsalus IC, Stanier RY, editors. The bacteria, Vol. 1. New York: Academic Press. pp 361-386.
7. Klieneberger E. 1935. The natural occurrence of pleuropneumonia-like organisms in aparent symbiosis with Streptobacillus moniliformis and other bacteria. J Path Bact 40:93-105.
8. Klieneberger E. 1936. Further studies on Streptobacillus moniliformis and its symbiont. J Path Bact 42:587-598.
9. Dienes L. 1939. Organisms of Klieneberger and Streptobacillus moniliformis. J Infect Dis 65:24-42.
10. Guze LB. 1968. Microbial protoplasts, spheroplasts and L-forms. Baltimore: The Williams & Wilkins Company.
11. Madoff S. 1986. The bacterial L-forms. New York: Marcel Dekker, Inc.
12. Pierce CH. 1942. Streptobacillus moniliformis, its associated L-form, and other pleuropneumonia-like organisms. J Bacteriol 43:780.
13. Lederberg J, St. Clair J. 1958. Protoplasts and L-type growth of Escherichia coli. J Bacteriol 75:143-160.
14. Domingue GJ, Woody HB. 1997. Bacterial persistence and expression of disease. Clin Microbiol Rev 10:320-344.
15. Onoda T, Oshima A, Nakano S, Matsuno A. 1987. Morphology, growth and reversion in a stable L-form of Escherichia coli K12. J Gen Microbiol 133:527-534.
16. Green MT, Heidger PM, Domingue G. 1974. Demonstration of the phenomena of microbial persistence and reversion with bacterial L-forms in human embryonic kidney cells. Infect Immun 10:889-914.
17. Braude AL, Siemienski J. 1970. Production of bladder stones by L-forms. Ann N Y Acad Sci 174:896-902.
18. Ponig B, Domingue GJ, Schlegel JU. 1972. The role of in vitro induced microbial L-forms in experimental hematogenous pyelonephritis. Invest Urol 9:282-285.
19. Domingue GJ, Turner B, Schlegel JU. 1974. Cell wall-deficient bacterial variants in kidney tissue. Detection by immunofluorescence. Urology 3:288-292.
20. Schmitt-Slomska J, Drach G, Caravano R. 1973. Incidence of cellular and humoral factors on group A streptococcal L-forms. I. Microscopic study of the association of L-forms with human polymorphonuclear leukocytes and mouse peritoneal macrophages. Ann Microbiol (Inst Pasteur) 124B:329-350.
21. Höltje JV. 1998. Growth of the stress-bearing and shape-maintaining murein sacculus of Escherichia coli. Microbiol Mol Biol Rev 62:181-203.
22. McCoy A, Maurelli AT. 2006. Building the invisible wall: updating the chlamydial peptidoglycan anomaly. Trends Microbiol 14:70-77.